Quick Order Cart

Cat. No. ARG40101

DVL2 Knockout HEK293T Polyclonal Cells

  • Product Type:

    Polyclonal Cell Population

  • Species:

    Homo sapiens (Human)

  • Tissue Source:

    Kidney

DVL2 Knockout HEK293T Polyclonal Cells are a CRISPR/Cas9-edited polyclonal knockout population of HEK293T cells, providing a loss-of-function model for the dishevelled segment polarity protein 2 (DVL2), a key scaffold in Wnt signaling. DVL2 mediates signal transduction from Frizzled receptors to ??-catenin stabilization and non-canonical pathways involving JNK and Rho GTPases. The knockout model is ideal for dissecting Wnt/??-catenin signaling, performing reporter assays (TOPFlash/FOPFlash), investigating protein interactions (AXIN1, GSK3??), and screening Wnt inhibitors. Suitable for cancer biology, EMT studies, and cell migration assays.

Inquire Now

In stock

Ships next business day


Ask a Question

Shipping Info:

Cryopreserved in vials and shipped on dry ice


Disclaimer:

For Research Use Only

  • Characteristics

    Host Cell

    HEK293T

    Sex of Donor

    Female

    Age

    Fetus

    Derived From Site

    Fetal kidney

    Gene Name

    DVL2

    Gene Identifier

    NCBI Gene ID 1856

    Growth Mode

    Adherent

    Storage

    Liquid nitrogen (LN2)

  • Culture Conditions

    Growth medium

    DMEM

    Supplement(s)

    10% Fetal Bovine Serum, 1% Penicillin-Streptomycin Solution

    Temperature

    37°C

    Atmosphere

    5% CO₂

  • Quality Control

    Sterility testing

    The bacterial, yeast, and fungi are not detected in these cells by daily monitor.

    Mycoplasma testing

    Negative for mycoplasma through PCR analysis

  • Disclaimer

    Intended Use

    This product is intended for laboratory in vitro use only. lt is not intended for diagnostic, therapeutic, or clinical applications.

    Disclaimer

    Ascent Research endeavors to provide accurate and up-to-date product information. However, no warranties or representations are made regarding its completeness or reliability. References to scientific literature and patents are for informational purposes only, and the customer assumes sole responsibility for verifying their accuracy.

    By accepting this product, the customer acknowledges and agrees to assume all risks associated with its receipt, handling, storage, disposal, and use, including compliance with all applicable safety and environmental regulations and precautions. Relevant laws, regulations, and ethical guidelines must be followed in conducting any research, modifications, or derivatives derived from this product.

    This product is provided "AS IS", and except as expressly stated herein, Ascent Research disclaims all other warranties, express or implied. Under no circumstances shall Ascent Research, its affiliates, or representatives be liable for indirect, incidental, consequential, or punitive damages arising from the use of this material. While Ascent Research employs rigorous quality control measures, we shall not be held responsible for damages resulting from misidentification or misinterpretation of the provided materials.

Description

The DVL2 Knockout HEK293T Polyclonal Cells comprise a CRISPR/Cas9-edited polyclonal knockout population of the HEK293T human cell line, offering a loss-of-function model for the DVL2 gene, which encodes the Wnt signaling scaffold dishevelled segment polarity protein 2. The polyclonal mixture contains cells with diverse DVL2 disruptions, suitable for bulk functional assays without clonal selection.

The HEK293T host cell line is a derivative of human embryonic kidney 293 cells, stably expressing SV40 large T-antigen for high-level plasmid amplification and protein expression. Widely used for transfection-based experiments, these adherent epithelial cells provide a robust background for studying signaling pathways, including Wnt, and are amenable to imaging, biochemical, and high-throughput applications.

DVL2 is a cytoplasmic phosphoprotein that acts as a central scaffold in Wnt signaling. Upon Wnt activation, receptors such as Frizzled and LRP5/6 bind DVL2, which polymerizes and recruits the AXIN1/GSK3??/APC destruction complex, inhibiting ??-catenin degradation. Stabilized ??-catenin enters the nucleus to activate TCF/LEF-mediated transcription of targets like MYC, CCND1, and AXIN2. In non-canonical pathways, DVL2 signals through ROR2/RYK to JNK and Rho GTPases (RhoA, RAC1), regulating cytoskeletal dynamics and cell polarity. DVL2 interacts with many partners, including CK1??, DAAM1, Vangl2, DACT1, and PRICKLE1, highlighting its role in pathway crosstalk.

In HEK293T cells, DVL2 disruption attenuates both canonical and non-canonical Wnt signaling, creating a clean background for mechanistic studies. The cell line??s high transfection efficiency enables rescue experiments with wild-type or mutant DVL2, facilitating structure-function analyses. This model is valuable for investigating Wnt-dependent processes such as ??-catenin stabilization, target gene induction, and EMT, as well as cross-talk with pathways like Hippo signaling. The polyclonal format minimizes clonal artifacts while supporting population-level readouts.

The DVL2 knockout polyclonal cells are suited for Wnt reporter assays (TOPFlash/FOPFlash), immunoblotting for active ??-catenin and downstream targets, co-immunoprecipitation of DVL2 complexes, and phospho-signaling analysis (JNK, c-Jun). They enable cancer research, drug screening for Wnt inhibitors, and studies of cell migration and polarity. For further information, please contact Ascent Research.

Reset Password

    Reach Us Questions? Click Me Here!

    Fill out the form below and a member of our team will contact you shortly!

    *Required field



      Reach Us

      Fill out the form below and a member of our team will contact you shortly!

      *Required field

      Product Inquiry (Optional)